Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs 1-4 . RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its messenger RNA selectivity is proposed to reflect highly structured 5′ untranslated regions that depend strongly on eIF4A-mediated unwinding 5 . However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actually increase the affinity between eIF4A and RNA 1,2,6 . Here we show that secondary structure in 5′ untranslated regions is only a minor determinant for RocA selectivity and that RocA does not repress translation by reducing eIF4A availability. Rather, in vitro and in cells, RocA specifically clamps eIF4A onto polypurine sequences in an ATP-independent manner. This artificially clamped eIF4A blocks 43S scanning, leading to premature, upstream translation initiation and reducing protein expression from transcripts bearing the RocA-eIF4A target sequence. In elucidating the mechanism of selective translation repression by this lead anti-cancer compound, we provide an example of a drug stabilizing sequence-selective RNA-protein interactions.
Indeed, we found that the eIF4A inhibitor hippuristanol (Hipp), which decreases the affinity between eIF4A and RNA 12, 13 , yields a different spectrum of mRNA-specific repression (Extended Data Fig. 4a-e ). The mTOR inhibitor PP242, which inhibits formation of eIF4F (a complex of eIF4E/G/A) 14, 15 , represses a subset of these Hipp-sensitive mRNAs (Extended Data Fig. 4f, g) . Thus, RocA exerts effects beyond reduced eIF4A activity, particularly at low, therapeutic doses.
We next asked how RocA affected eIF4A occupancy across the transcriptome in cells by sequencing transcripts that co-purified with streptavidin binding peptide (SBP)-tagged eIF4A (Extended Data 
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RocA doses elevated the overall amount of RNA that co-purified with SBP-tagged eIF4A (Extended Data Fig. 5d ), and greatly changed the abundance of individual transcripts, leading to 15-fold or larger differences between mRNAs. Strikingly, enhanced eIF4A binding in the presence of RocA correlated strongly with translation inhibition by RocA ( Fig. 1d and Extended Data Fig. 5f ), suggesting that a selective increase of the eIF4A-RNA affinity underlies the specific translation inhibition caused by RocA. This mRNA selectivity led us to explore the sequence preferences of eIF4A in the absence and presence of RocA. We measured the RNAs that bound to eIF4A out of a random pool of oligonucleotides using deep sequencing (RNA Bind-n-Seq) 16 (Extended Data Fig. 6a -c). We then calculated the enrichment of 4-to 6-nucleotide (nt) motifs in RNAs retained on eIF4A, as DEAD-box RNA helicases typically contact 6 nt (ref. 17) . The motifs enriched from randomized synthetic RNA by Bind-n-Seq also predicted RIP-seq enrichments of endogenous transcripts ( Fig. 2a and Extended Data Fig. 6d ). In both experiments, RocA greatly enhanced binding to short polypurine sequences (Fig. 2b, c and Extended Data Fig. 6e ). Although drug-free eIF4A also had intrinsic RNA sequence preferences 18 (Extended Data Figs 6g) and transcripts containing these preferred sequences were relatively resistant to Hipp treatment (Extended Data Fig. 6h ), RocA only selectively increases binding to a subset of sequences containing polypurine stretches (Extended Data Fig. 6g ).
Polypurine motifs were also enriched in the eIF4A binding sites detected by photocrosslinking and immunoprecipitation (iCLIP) 19 after RocA treatment ( Fig. 2d and Extended Data Fig. 7) , and in the 5′ UTRs of translationally RocA-sensitive mRNAs ( Fig. 2e ). This striking correspondence among in vitro binding to recombinant protein, ex vivo co-purification, crosslinking in cells, and translational repression in cells led us to hypothesize that selective binding to polypurine motifs induced by RocA binding could explain mRNA-specific translational repression. We then directly confirmed that inserting the polypurine motif into an unstructured CAA repeat 5′ UTR (Extended Data Fig. 9a ) 20 sensitized the reporter to RocA inhibiton ( Fig. 2f ).
We found that RocA-induced, sequence-selective eIF4A binding occurs through ATP-independent clamping that suffices to repress translation of the clamped mRNA. The cycle of ATP-dependent RNA binding and subsequent release upon ATP hydrolysis is necessary for the efficient RNA remodelling activity of eIF4A as well as its role in translation 21 . Drug-free eIF4A bound RNA only in the presence of ATP (AMP-PNP and ADP-BeF x ) and transition state (ADP-AlF 4 ) analogues but not hydrolysis products (ADP + Pi). Remarkably, RocA clamped eIF4A on polypurine RNA, but not CAA-repeat RNA, in an ATPindependent manner (Fig. 3a, b and Extended Data Fig. 8a, b ). Bindn-Seq performed with ADP + Pi likewise recovered polypurineenriched RNAs in the presence of RocA and no detectable RNA in the absence of RocA ( Fig. 3c and Extended Data Fig. 6i ). RocA provided polypurine-specific RNA binding activity to mutant eIF4A defective for ATP binding (VX 4 GKT) 22 , which does not bind to RNA at all without RocA (Extended Data Fig. 8d -f), and even to the truncated amino (N)-terminal domain of eIF4A, albeit with lower affinity (Extended Data Fig. 8g ). The eIF4A/RocA complex dissociated far more slowly from polypurine RNA than naive eIF4A, even in the presence of ATP, whose hydrolysis ordinarily permits rapid dissociation ( Fig. 3d ). High RNA affinity in the ADP-bound state can prolong RNA binding beyond the time required for adenosine nucleotide exchange to restore the high-affinity ATP-bound state and thus greatly reduce the effective dissociation rate. This effective dissociation rate from polypurine RNA measured in hydrolysable ATP (reflective of the intracellular environment) becomes much slower than the ~ 1 min timescale of translation initiation 23 , and could serve to directly block the ribosome.
To probe how clamped eIF4A repressed translation, we recapitulated RocA-induced, polypurine motif-specific translational repression Fragment length (nt) 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 10 -2 10 -1 10 0 10 1 Letter reSeArCH in rabbit reticulocyte lysate (RRL) (Extended Data Fig. 9b , c). In this system, RocA treatment represses the formation of 48S pre-initiation complexes on the start codon of sensitive mRNAs, which we assessed using a primer extension toeprinting assay 20, 24 (Fig. 3e and Extended Data Fig. 9d) . Surprisingly, we observed additional RocA-dependent toeprints on the 5′ UTR, corresponding to the position of polypurine motifs ( Fig. 3e ), even without eIF4F recruitment (Extended Data Fig. 9e ). We recapitulated these toeprints using only purified eIF4A and drug, showing that they reflect eIF4A/RocA complexes clamped directly onto polypurine motifs, bypassing its canonical recruitment via cap and the eIF4F complex 21 (Extended Data Fig. 9f ). RNase I footprinting revealed the full extent of the eIF4A protected region centred on the motif ( Fig. 3f and Extended Data Fig. 9g ).
These eIF4F-independent eIF4A/RocA complexes directly repress translation. We pre-formed such stable complexes on an mRNA during a pre-incubation with recombinant eIF4A and RocA, and then showed that they repressed its subsequent translation in the absence of free RocA (Fig. 4a ). Recombinant forms of eIF4A bearing mutations that disrupt either ATP binding or eIF4G binding still retained the ability to clamp onto polypurine RNA in the presence of RocA (Extended Data Figs 8d-f, h, i and 9h-i) and repress translation from the RNA as strongly as wild-type eIF4A/RocA complex (Extended Data Fig. 9j ). Furthermore, supplementation of recombinant eIF4A protein into an in vitro translation reaction actually strengthened the repressive effect of RocA ( Fig. 4b and Extended Data Fig. 9k ), confirming the dominant repressive effect of the eIF4A/RocA complex. In contrast, translation repression by Hipp, which decreases the affinity between eIF4A and RNA and thereby mimics a loss of its function, was relieved by the addition of recombinant eIF4A.
Assembly of an eIF4A/RocA complex could in principle repress 48S formation by blocking 40S attachment to the 5′ end of an mRNA or subsequent 43S scanning along the 5′ UTR. Because the impact of eIF4A/RocA bound to a single polypurine motif is unaffected by its distance from the 5′ end (Extended Data Fig. 9a , l), we infer that eIF4A/RocA bound to these motifs blocks 43S scanning. We also found that eIF4A/RocA could inhibit translation from the polio virus internal ribosome entry site (IRES), which bypasses ordinary 40S recruitment but still depends on scanning (Extended Data Fig. 9a ) 25 when we inserted polypurine motifs in the scanned region ( Fig. 4c and Extended Data Fig. 9m ). Scanning inhibition suffices to explain repression by the eIF4A/RocA complex, although our data do not exclude an additional effect on 40S loading. Impediments to 43S scanning by stable hairpins 26 or RNA-binding proteins 27 can enhance the translation from upstream open reading frames (uORFs) that otherwise would be skipped. We observed that RocA treatment, but not Hipp treatment, caused an analogous accumulation of translation on 5′ UTRs despite the global reduction in footprints on protein-coding sequences (CDSes) (Extended Data Fig. 10a, b ). This enhancement occurred specifically on high-sensitivity transcripts ( Fig. 4d and Extended Data Fig. 10c ). The uORFs activated by RocA showed enrichment of a polypurine motif 20-30 nt downstream of the uORF initiation codon (Fig. 4d , inset), reflecting the distance between the start site and the leading edge of the scanning complex 27 . We tested directly whether eIF4A/RocA complexes on polypurine motifs
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can drive cryptic upstream initiation using a reporter mRNA with two alternative start sites that yield distinguishable protein isoforms. Insertion of a polypurine motif 30 nt downstream of the earlier AUG increased translation initiation from this codon upon RocA treatment ( Fig. 4e ), confirming that clamped eIF4A/RocA complexes on polypurine motifs drive upstream translation initiation. We found evidence that that this enhanced upstream initiation could contribute to eIF4A/ RocA-mediated repression of downstream CDSes 28 , as RocA-sensitive transcripts showed more pre-existing uORF initiation 29 (Extended Data Fig. 10d, e ).
We have shown that RocA induces ATP-independent clamping of eIF4A onto polypurine sequences, creating an inhibitory roadblock for the scanning ribosome ( Fig. 4f ). Our identification of the eIF4A/RocA binding motif provides the first observation of a drug that stabilizes sequence-selective RNA-protein interactions 30 . RocA may bind near the RNA interface on the N-terminal domain of eIF4A 6 , raising the possibility that the drug directly contacts purine bases of target RNAs. Alternatively, RocA might induce a conformational change leading to direct or indirect recognition of the polypurine motif by protein residues. Future structural insight into this polypurine selectivity may enable rocaglate derivatives with altered base selectivities that target different mRNA.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 

MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. General methods. HEK 293 Flp-In T-Rex cells (Invitrogen) were cultured and recombined according to manufacturer's instructions. Stable integrants of SBP-tagged eIF4A were produced by co-transfection of these plasmids along with pOG44 by X-tremeGENE 9 (Roche) and selection using Hygromycin B. RocA, PP242, and thapsigargin were purchased from Sigma. Proteins and DNAs/RNAs were stained with GelCode Blue Stain Reagent (Thermo Scientific) and SYBR Gold Nucleic Acid Gel Stain (Invitrogen), respectively. Ribosome profiling. Library preparation and data analysis were performed according to the method previously described 31 , which monitors mitochondrial ribosomes as well 8, 31 . DMSO, RocA, Hipp, and PP242 were added to medium 30 min before cell lysis. The libraries were sequenced on a HiSeq 2000/2500 (Illumina). RIP-seq. Cells with tetracycline-inducible, SBP-tagged eIF4A integrated stably were plated in a 10 cm dish and cultured for 3 days with 1 μ g ml −1 tetracycline, incubated with DMSO, 0.03 μ M, or 0.3 μ M RocA for 30 min, washed once with 5 ml of ice-cold PBS, lysed with 600 μ l of lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , and 1 mM DTT) containing 1% Triton X-100 and Turbo DNase I (Invitrogen) 25 U ml −1 , and then clarified by centrifugation for 10 min at 20,000g, 4 °C. The supernatant was incubated with 60 μ l of Dynabeads M-270 Streptavidin (Invitrogen) equilibrated with lysis buffer containing 1% Triton X-100 at 4 °C for 30 min. The beads were washed five times with lysis buffer containing 1% Triton X-100 and 1 M NaCl. SBP-eIF4A and bound RNAs were eluted with 25 μ l of lysis buffer containing 5 mM biotin at 4 °C for 30 min. All buffers contained 0.001% DMSO with or without 0.03 or 0.3 μ M RocA. RNAs were extracted with QIAzol (Qiagen) using the Direct-zol RNA miniprep (Zymo Research). One-third of eluted RNA (~ 100 ng) was mixed with 1 ng of in vitro transcribed, spike-in Renilla luciferase RNA (hRluc) (see 'DNA constructs') and sequencing libraries were prepared using Tru-seq Ribo-zero gold kit (Illumina). Libraries were sequenced on HiSeq2000/2500 (Illumina) sequencers. iCLIP. Cells were cultured as described in 'RIP-seq' . After medium was substituted with ice-cold PBS, the dishes on ice were irradiated with 150 mJ cm −2 with UV-C (~ 254 nm) in UVP CL-1000 (UVP). Lysate was prepared as described in 'RIP-seq' . The lysate from a 10 cm dish (600 μ l) was treated with 0.4 U of RNase I (Epicentre) at 37 °C for 3 min. Reaction was quenched by the addition of 10 μ l of SUPERase In RNase Inhibitor (Invitrogen), and then incubated with 60 μ l of Dynabeads M-270 Streptavidin (Invitrogen) equilibrated with lysis buffer containing 1% Triton X-100 at 4 °C for 30 min. The beads were washed by CLIP wash buffer (20 mM Tris-Cl pH 7.4, 1 M NaCl, 2 mM EDTA, 1 mM DTT, and 1% Triton X-100) twice, by CLIP wash buffer containing 0.1% SDS and 0.05% sodium deocycholate twice, and then by lysis buffer containing 1% Triton X-100 twice. After discarding the supernatant, the beads were incubated with 10 U T4 PNK (NEB), 1× PNK buffer, and 0.33 μ M 32 P-γ [ATP] (3,000 Ci mmol −1 , PerkinElmer) in 10 μ l at 37 °C for 5 min and washed once with lysis buffer containing 1% Triton X-100. RNA-crosslinked proteins were eluted by 20 μ l of lysis buffer containing 1% Triton X-100 and 5 mM biotin at 37 °C for 5 min, run onto NuPAGE (Invitrogen), and transferred to nitrocellulose membrane 0.45 μ m (Biorad). The images of 32 P-labelled RNAprotein complex on the membrane were acquired by Typhoon TRIO (Amersham Biosciences). The membrane with the region containing SBP-eIF4A/RNA complexes was excised and treated with 0.1 μ g μ l −1 Proteinase K (Thermo Scientific), 200 mM Tris-Cl, pH 7.4, 25 mM EDTA, pH 8.0, 300 mM NaCl, and 2% SDS in 200 μ l at 55 °C for 20 min. RNAs were isolated by phenol/chloroform extraction and ethanol precipitation. Library preparation was performed according to the method previously described 31 TACACGACGCTC-3′ a n d 5 ′ -CAAGCAGAAGACGGCATACGAGATCGT GATGTGACTGGAGTTCAGACGTGTG-3′ . Libraries were sequenced on HiSeq4000 (Illumina) sequencers. Random barcode was used to eliminate PCR duplicates in the library. Bind-n-Seq. SBP-tagged eIF4A was purified as described in 'RIP-seq' , without DMSO or RocA treatment. The beads tethering SBP-eIF4A were treated with 1× Micrococcal Nuclease Buffer (NEB), 0.5× lysis buffer, 0.5% Triton X-100, and 200 U μ l −1 Micrococcal Nuclease (NEB) in 30 μ l at 25 °C for 30 min, washed five times with lysis buffer containing 1% Triton X-100, 1 M NaCl, and 5 mM EGTA pH 7.4, and rinsed twice with lysis buffer containing 0.1% Triton X-100. The beads were incubated in lysis buffer containing 0.1% Triton X-100, 2 mM AMP-PNP, 0.33 U μ l −1 SUPERase In RNase Inhibitor (Invitrogen), 1 μ M N 30 RNA ((N) 30 CTGTAGGCACCATCAAT, where letters in bold type represent DNA sequence for reverse transcription primer hybridization) in 30 μ l at 37 °C for 30 min, and washed five times with lysis buffer containing 0.1% Triton X-100, 2 mM AMP-PNP, and 0.1% DMSO. SBP-eIF4A/RNA complex was eluted with 30 μ l of lysis buffer containing 0.1% Triton X-100, 2 mM AMP-PNP, and 5 mM biotin. DMSO (0.1%) with or without 30 or 300 nM RocA was present in all buffers during the RNA binding reaction, wash, and elution. RNAs were extracted with QIAzol (Qiagen) using the Direct-zol RNA miniprep (Zymo Research) and converted into DNA library as the same method of ribosome profiling 31 . For Bind-n-Seq with ADP + Pi, 2 mM ADP, 2 mM Na 2 HPO 4 , 50 μ M N 30 RNA, and 3 μ M RocA were used.
The 30-nt randomized RNA followed by 3′ DNA sequence for reverse transcription priming was designed to avoid ligation biases and sequencing of contaminating RNA fragments from cells during SBP-eIF4A purification, and to cover the entire sequence with a single 50-bp mode of HiSeq (Illumina) sequencers.
Our read depth (~ 10 8 reads) is less than the theoretical complexity (4 30 ≈ 10 18 ), so that the probability that the same sequence appears multiple times in the library is quite low. Therefore, we assumed that reads with exactly the same sequence and length in the library reflect PCR duplicates and counted them only once. Motif enrichment in the range of interest (4-6 nt) was calculated as the ratio of the motif frequency between libraries 16 .
Spearman's correlation of motif number in 5′ UTR versus RIP-seq -fold change caused by RocA treatment was used as motif prediction in RIP-seq. High-scoring motifs were defined as those with enrichment of the prediction or the enrichment is > 1.5 s.d. from the mean in RIP-seq and Bind-n-Seq, respectively. Data analysis. The reads were aligned to the hg19 human genome reference and the resulting aligned reads were mapped to University of California, Santa Cruz (UCSC) known reference genes, downloaded from the UCSC genome browser in July 2013. A UCSC bed file of known genes was used for the 5′ UTR analysis. For mitochondria footprints alignments, we used the RefSeq genes track corresponding to the mitochondrial chromosome (chrM), downloaded from UCSC genome browser. Specific A-site nucleotides were empirically estimated on the basis of the length of each footprint. The offsets were 14 for 26-29 nt and 15 for 30-31 nt. For mitochondria footprints, they were 9 for 26-27 nt, 11 for 28-29 nt, 12 for 30 nt, 13 for 31 nt, and 18 for 32-34 nt. For mRNA fragments, we used offset 14. For measuring footprint density and mRNA fragments of RIP-seq between samples, we restricted our analysis to genes, which have at least 40 and 100 summed counts in each sample, respectively. For CDSs, the analysis only included the transcript positions beginning 15 codons following the start codon and stopping 5 codons preceding the stop codon. For 5′ UTRs, we included the transcript positions from the 5′ end of the mRNA until 5 codons preceding the start codon. DESeq 32 was used to calculate relative enrichment of genes in the library, including the mitochondrial footprints and spike-in hRluc mRNA counts. The calculated -fold change was re-normalized to the value of the summed mitochondria footprints or the spike-in hRluc mRNA fragments.
High-sensitivity messages were defined as transcripts with reduction more than twofold from the median, and with q value < 0.01, between 3 μ M RocA-treated and untreated cells. Low-sensitivity transcripts are defined as same as high-sensitivity but with accumulation over twofold.
For calculation of Δ G, RNALfold (ViennaRNA Package) 33 was run with -L30 -g options on 5′ UTR sequences from UCSC foldUtr5 table. The minimum Δ G along each 5′ UTR was used as a representative free energy value for each gene.
The presence of G-quadruplexes was predicted with RNAfold (ViennaRNA Package).
The Gini differences across 5′ UTRs were calculated using published data 11 . Analysis was restricted to the mRNAs bearing 5′ UTRs having one or more reads on A/C positions on average. 'uORF translation intensity' was calculated using published data 29 . To incorporate the number and intensity of each upstream initiation site in the 5′ UTR, we calculated the density of 5′ UTR footprints for each transcript as mentioned above, as the great majority of these footprints derive from ribosomes trapped on first codons (Extended Data Fig. 10d ). To normalize mRNA abundance in cells, we normalized the density by footprint counts from the CDS start codon region using the genomic position between start codon and 6 nt downstream. We restricted the analysis to transcripts with at least ten counts from CDS start codons and re-normalized the value to the median as one. Code availability. Scripts to run the analyses mentioned above are available upon request. Fluorescence polarization assay. Proteins (0-50 μ M) were incubated in 14.4 mM HEPES-NaOH, 108 mM NaCl, 1 mM MgCl 2 , 0.36 mM TCEP, 14.4% glycerol, 0.1% DMSO, and 10 nM 5′ FAM-labelled RNA with or without 50 μ M RocA in 10 μ l reaction for 30 min at 25 °C. The experiments were performed with 1 mM AMP-PNP (for AMP-PNP), 1 mM ADP, 5 mM BeCl 2 , and 25 mM NaF (for ADP-BeF x ), 1 mM ADP, 5 mM AlCl 3 , and 25 mM NaF (for ADP-AlF 4 ), or 1 mM ADP and 1 mM Na 2 HPO 4 (for ADP + Pi). For the condition without ATP analogue, MgCl 2 was omitted from the reaction.
For competition assay, the complexes were preformed with 1 mM ATP or AMP-PNP, 1 μ M eIF4A, 10 nM FAM-labelled RNA, and 50 μ M RocA and chased with 100 μ M non-labelled RNA. Because of the low affinity, 50 μ M eIF4A was used with ATP and DMSO.
Fluorescence polarization was measured using an Infinite F-200 PRO (TECAN). The dissociation constant (K d ) and half-life (t 1/2 ) were calculated with fitting to the Hill equation and one-phase exponential decay equation, respectively, by Igor Pro software (WaveMatrics). In vitro translation and toeprinting assay. In vitro translation was performed with nuclease-treated RRL system (Promega), according to the manufacturer's instructions. Reporter mRNAs (50 nM; see 'DNA constructs') was incubated in 50% RRL with RocA (concentration shown in the figure legends) or 1% DMSO in 10 μ l at 30 °C for 1 h. For the detection of SBP, 20 μ l of the reaction was used with uORF + CAACAA or uORF + AGAGAG mRNAs and concentrated with 10 μ l of Dynabeads M-270 Streptavidin (Invitrogen).
The toeprinting assay was performed as previously described 34 . The reaction was pre-incubated with RRL in the presence of 2 mM GMP-PNP or m 7 GTP and 3 μ M RocA or 1% DMSO at 30 °C for 5 min, and then incubated with 50 nM mRNAs at 30 °C for 5 min, followed by reverse transcription with 10 U μ l Dideoxy-terminated sequencing of RNA was performed by reverse transcriptions using 0.125 mM individual dideoxy-NTP and 0.5 mM each deoxy-NTP with the same 5′ 6-FAM-labelled primer and ProtoScript II, according to the manufacturer's instructions. RNase I footprinting assay. Reporter RNA was incubated with recombinant eIF4A and RocA in 12 μ l as described for the toeprinting assay. The reaction was treated with 1 μ l of 0.001 U μ l −1 RNase I (Epicentere) at room temperature for 5 min. After quenching the digestion by the addition of 1 μ l of SUPERase In RNase Inhibitor (Invitrogen), RNA was extracted by Oligo Clean & Concentrator (Zymo Research) and reverse transcribed by ProtoScript II (NEB) with 5′ 6-FAM labelled primer (5′ -6-FAM-ATGCAGAAAAATCACGGC-3′ ) according to the manufacturer's intructions. The cDNA was run on 3730 DNA Analyzer (Life Technologies) as described for the toeprinting assay. Data were analysed by GeneMapper software (Life Technologies). Polysome profiling. Cell lysate was prepared as described previously 31 . Lysate containing 15 μ g total RNA was loaded on to 10-50% linear sucrose gradients containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 100 μ g ml −1 cycloheximide, and 2 U ml −1 SUPERase In RNase Inhibitor and sedimented by ultracentrifugation at 220,000g for 2 h at 4 °C with an SW41 rotor (Beckman Coulter). Gradients were fractionated using Gradient station (Biocomp). Ultraviolet absorbance was detected by ECONO UV monitor (Biorad). Metabolic labelling of nascent peptide by OP-puro. Nascent peptides in HEK 293 cells were labelled by 40 μ M OP-puro (Jena Bioscience) in 24-well dishes with 0-3 μ M RocA for 30 min. Cells were washed with PBS and lysed with 50 μ l of lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , and 1 mM DTT) containing 1% Triton X-100, and then clarified by centrifugation with 20,000g at 4 °C for 10 min. Nascent peptides were labelled with 5 μ M Alexa Fluor 488 Azide (ThermoFisher Scientific) by a Click-it Cell Reaction Buffer Kit (ThermoFisher Scientific) according to the manufacturer's instructions and run on SDS-PAGE. Images were acquired by FluorChem R imaging sysmtem (ProteinSimple) and quantified by AlphaView (ProteinSimple). DNA constructs. DNA fragments containing 5′ UTRs sequences, listed below, were inserted between T7 promoter and ORF of Renilla luciferase (hRluc) in psiCHECK2 (Promega). We cloned exactly the same sequence of G-quadruplex and its control sequence used in ref. 5 . These plasmids were digested by NotI and used as in vitro transcription template.
EIF2S3 (uc004dbc.3): TTTCCTTCCTCTTTTGGCAAC. CG TG CC CC CG CA AG AC TG CT AG CC GAGTAGTGTTGGGTCGCGAAAGGC  CTTGTGGTACTGCCTGATAGGGTGCTTGCGAGTGCCCCGGGAGGTCTC  GTAGACCGTGCACCATGAGCACGAATCCTAAACCTCAAAGAAAAACCA  AACGTAAC. G-quadruplex: CTAGGTTGAAAGTACTTTGACGGCGGCGGCGGTCAA TCTTACGGCGGCGGCGGACATAGATACGGCGGCGGCGGTAGAAACTA CGGCGGCGGCGGATTAGAATAGTAAA (where letters in bold type represent G-quadruplex-forming sequences).
HNRNPC (uc001vzy.3): A G G A A T G G G G C G G G G A C T A G G C C T T C G C C T C GG C G G C A G A G G A G A C T C G G G G G C C A T T T T G T G AA G A G A C G A A G A C T G A G C G G T T G T G G C C G C G T TG C C G A C C T C C A G C A G CA G T C G G C T T C T C T A C GC A G AA C C CG G G AG T A GG
HCV I RE S: G C C A G C C C C C T G A T G G G G G C G A C A C T C C A C C A T G A A T C A C T C C C C T G T G A G G A A C T A C T G T C T TC A C G C A G A A A G C G T C T A G C C A T G G C G T T A G T A T G A G T G T C G T G C A G C C T C C A G G A C C C C C C C T CC C G G G A G A G C C A T A G T G G T C T G C G G A A C C G G TG A G T A C A C C G G A A T T GC C A G G A C GA C C G G G T CC T T T C T T GG A G TT A C CC G C TC A A TG C C TG G A GA T T TG GG
Randomized control for G-quadruplex: CTAGGGCGCACGTACTT CGACAACGTCAGCGTTCAGCGTTCCAACGTCAGCGTACAGCGATCCAA CGTCAGCGTTCTGCGCTACAACGTCAGCGTATCCGCGTAGCACA.
CAA repeat: GAACAACAACAACAACAACAACAACAACAACAAC AACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAA CACC.
7× AGAGAG motifs: GAAAGAGAGCAACAAAGAGAGCAACAAAGAG AGCAACAAAGAGAGCAACAAAGAGAGCAACAAAGAGAGCAACAAAGA GAGCACC.
1× AGAGAG left: GAAAGAGAGCAACAACAACAACAACAACAA CAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAA CAACACC.
1× AGAGAG middle: GAACAACAACAACAACAACAACAACAACAACAA CAACAAAGAGAGCAACAACAACAACAACAACAACAACAACAACAACAA CACC.
1× AGAGAG right: GAACAACAACAACAACAACAACAACAACAACAA CAACAACAACAACAACAACAACAACAACAACAACAACAACAAAGAGA GCACC.
Polio virus IRES: TTAAAACAGCTCTGGGGTTGTACCCACCCCAG  AGGCCCACGTGGCGGCTAGTACTCCGGTATTGCGGTACCCTTGTACGC  CTGTTTTATACTCCCTTCCCGTAACTTAGACGCACAAAACCAAGTTCAA  TAGAAGGGGGTACAAACCAGTACCACCACGAACAAGCACTTCTGTTTC  CCCGGTGATGTCGTATAGACTGCTTGCGTGGTTGAAAGCGACGGATCCG  TTATCCGCTTATGTACTTCGAGAAGCCCAGTACCACCTCGGAATCTTCG  ATGCGTTGCGCTCAGCACTCAACCCCAGAGTGTAGCTTAGGCTGATGAG  TCTGGACATCCCTCACCGGTGACGGTGGTCCAGGCTGCGTTGGCGGCC  TACCTATGGCTAACGCCATGGGACGCTAGTTGTGAACAAGGTGTGAAG  AGCCTATTGAGCTACATAAGAATCCTCCGGCCCCTGAATGCGGCTAATC  CCAACCTCGGAGCAGGTGGTCACAAACCAGTGATTGGCCTGTCGTAAC  GCGCAAGTCCGTGGCGGAACCGACTACTTTGGGTGTCCGTGTTTCCTT  Letter  reSeArCH   TTATTTTATTGTGGCTGCTTATGGTGACAATCACAGATTGTTATCATAAA  GCGAATTGGATTGGCCATCCGGTGAAAGTGAGACTCATTATCTATCTG  TTTGCTGGATCCGCTCCATTGAGTGTGTTTACTCTAAGTACAATTTCAAC  AGTTATTTCAATCAGACAATTGTATCATA.  Polio virus IRES 3× AGAGAG: TTAAAACAGCTCTGGGGTTGTA  CCCACCCCAGAGGCCCACGTGGCGGCTAGTACTCCGGTATTGCGGTACC  CTTGTACGCCTGTTTTATACTCCCTTCCCGTAACTTAGACGCACAAAACC  AAGTTCAATAGAAGGGGGTACAAACCAGTACCACCACGAACAAGCACTT  CTGTTTCCCCGGTGATGTCGTATAGACTGCTTGCGTGGTTGAAAGCGA  CGGATCCGTTATCCGCTTATGTACTTCGAGAAGCCCAGTACCACCTCGG  AATCTTCGATGCGTTGCGCTCAGCACTCAACCCCAGAGTGTAGCTTAG  GCTGATGAGTCTGGACATCCCTCACCGGTGACGGTGGTCCAGGCTGCG  TTGGCGGCCTACCTATGGCTAACGCCATGGGACGCTAGTTGTGAACAA  GGTGTGAAGAGCCTATTGAGCTACATAAGAATCCTCCGGCCCCTGAAT  GCGGCTAATCCCAACCTCGGAGCAGGTGGTCACAAACCAGTGATTGG  CCTGTCGTAACGCGCAAGTCCGTGGCGGAACCGACTACTTTGGGTGTC  CGTGTTTCCTTTTATTTTATTGTGGCTGCTTATGGTGACAATCACAGATT  GTTATCATAAAGCGAATTGGATTGGCCATCCGGTGAAAGTGAGACTCAT  TATCTATCTGTTTGCTGGATCCGCTCCATTGAGAGAGTTTACTCTAAGT AGAGAGTCAACAGTTATTAGAGAGAGACAATTGTATCATA.
The For the generation of stable cell-lines, PCR products containing CDS regions of EIF4AI mRNA and SBP amplified from cDNA from human adult normal brain (Invitrogen) and from pASW 35 (a gift from Y. Tomari), respectively, were inserted into HindIII site in pcDNA5/FRT/TO (Invitrogen) by Gibson assembly (NEB). P159Q, F163L, and Q195E mutations were introduced by sitedirected mutagenesis.
For recombinant eIF4A protein expression, PCR products containing CDS regions of EIF4AI mRNA were inserted into pHM-GWA 36 to construct pHisMBP-eIF4A. VX 4 GKT (A82V) and D296A-T298K mutations were introduced by sitedirected mutagenesis. His-tag, MBP-tag, tobacco etch virus protease cleavage site, and the N-terminal region of eIF4A (1-237) were cloned into pET-28a, to construct pHisMBP-eIF4A (1-237). Reporter assay in HEK 293 cells. Transfections were performed in 24-well dishes with a TransIT-mRNA Transfection Kit (Mirus) according to the manufacturer's instructions, at half scale. Three hours after transfection, RocA was added to the medium, and 9 h after transfection cells were washed with PBS and lysed with Passive lysis buffer (Promega). The luciferase assay was performed with Renilla-Glo Luciferase Assay System (Promega) according to the manufacturer's instructions. Luminescence was detected with a GloMax-Multi Jr System (Progema).
For stable cell lines with SBP-tagged eIF4A and its mutants, HEK 293 Flp-In T-Rex cells were cultured for 4 days with 1 μ g ml −1 tetracycline before the experiments. Tetracycline was included in media during experiments. Quantitative PCR. Cell lysate or in vitro translation reaction for luciferase assay was treated with 40 U ml −1 TurboDNase for 10 min on ice, and then RNA was extracted by TRI Reagent (Sigma) and Direct-zol RNA MiniPrep (Zymo Research). Reverse transcriptions were performed with ProtoScript II (NEB) and random 
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